0001209191-21-009760.txt : 20210211
0001209191-21-009760.hdr.sgml : 20210211
20210211170432
ACCESSION NUMBER: 0001209191-21-009760
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210209
FILED AS OF DATE: 20210211
DATE AS OF CHANGE: 20210211
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Daniel Jennifer
CENTRAL INDEX KEY: 0001797725
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39206
FILM NUMBER: 21620708
MAIL ADDRESS:
STREET 1: SCHRODINGER, INC.
STREET 2: 120 WEST 45TH STREET, 17TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10036
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Schrodinger, Inc.
CENTRAL INDEX KEY: 0001490978
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 954284541
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 120 WEST 45TH STREET
STREET 2: 17TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10036
BUSINESS PHONE: 503-299-1150
MAIL ADDRESS:
STREET 1: 120 WEST 45TH STREET
STREET 2: 17TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10036
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-02-09
0
0001490978
Schrodinger, Inc.
SDGR
0001797725
Daniel Jennifer
C/O SCHRODINGER, INC.,
120 WEST 45TH STREET, 17TH FLOOR
NEW YORK
NY
10036
0
1
0
0
SVP & Chief HR Officer
Common Stock
2021-02-09
4
M
0
2006
17.00
A
8694
D
Common Stock
2021-02-09
4
S
0
2006
104.81
D
6688
D
Common Stock
2021-02-10
4
M
0
2007
17.00
A
8695
D
Common Stock
2021-02-10
4
S
0
2007
105.46
D
6688
D
Common Stock
2021-02-11
4
M
0
2007
17.00
A
8695
D
Common Stock
2021-02-11
4
S
0
2007
106.07
D
6688
D
Stock Option (right to buy)
17.00
2021-02-09
4
M
0
2006
0.00
D
2030-02-05
Common Stock
2006
34113
D
Stock Option (right to buy)
17.00
2021-02-10
4
M
0
2007
0.00
D
2030-02-05
Common Stock
2007
32106
D
Stock Option (right to buy)
17.00
2021-02-11
4
M
0
2007
0.00
D
2030-02-05
Common Stock
2007
30099
D
These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2020.
This option was granted on February 5, 2020. The shares underlying the option vested with respect to 25% of the shares on February 5, 2021 and the remainder are scheduled to vest in equal monthly installments through February 5, 2024.
/s/ Donald Shum, as attorney-in-fact for Jennifer Daniel
2021-02-11